Related Experiment Video
Updated: Feb 24, 2026
07:44
Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
18.6K
Array-Based Rational Design of Short Peptide Probe-Derived from an Anti-TNT Monoclonal Antibody
Mina Okochi1,2, Masaki Muto1,2, Kentaro Yanai1
1Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology , 2-12-1, O-okayama, Meguro-ku, Tokyo 152-8552, Japan.
ACS Combinatorial Science
|August 29, 2017
Summary
Researchers identified a short peptide from antibody complementarity-determining regions (CDRs) that binds 2,4,6-trinitrotoluene (TNT). This peptide, derived from heavy chain CDR3, shows potential for developing new sensors for volatile organic compounds.
Area of Science:
- Immunology
- Biochemistry
- Materials Science
Background:
- Antibodies utilize complementarity-determining regions (CDRs) for antigen binding.
- Developing specific probes for small molecules like 2,4,6-trinitrotoluene (TNT) is crucial for detection.
Purpose of the Study:
- To identify and characterize a peptide sequence derived from antibody CDRs with specific binding affinity for TNT.
- To explore the potential of CDR-derived peptides as building blocks for novel sensor development.
Main Methods:
- Antigen docking simulations were employed to predict TNT-binding sites within an anti-TNT monoclonal antibody.
- Peptide arrays synthesized from antibody CDR sequences were used for immunoassay validation.
- Surface plasmon resonance (SPR) was utilized to quantify the binding affinity (dissociation constant) of the identified peptide to TNT.
Main Results:
- A peptide sequence from the heavy chain CDR3 (RGYSSFIYWF) demonstrated specific binding to TNT.
- The dissociation constant for the TNT-peptide interaction was measured at 1.3 μM via SPR.
- Amino acid substitutions, particularly with basic residues, enhanced TNT binding affinity, with an isoleucine to arginine change yielding a 1.8-fold improvement.
Conclusions:
- Antibody CDR sequences can be repurposed to create specific peptide binders for small molecules like TNT.
- Engineered peptide binders derived from immune system information hold promise for future sensor applications, particularly for volatile organic compounds.
